NCT06466057 Metacognitive Therapy for Obsessive-Compulsive Disorder
| NCT ID | NCT06466057 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northeast Normal University |
| Condition | Obsessive-Compulsive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-06-11 |
| Primary Completion | 2024-09-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The goal of this clinical trial is to learn if metacognitive therapy can be effective in a Chinese sample of obsessive compulsive disorder (OCD) . The main questions it aims to answer are: Can metacognitive therapy significantly reduce participants' levels of obsessive-compulsive symptoms? Can metacognitive therapy significantly improve participants' metacognitive adaptations? The researchers will compare metacognitive therapy to a control condition without psychotherapy to see if metacognitive therapy is effective in treating OCD. Participants will: Receive the metacognitive therapy intervention or under control conditions for 8 to 15 weeks. Be assessed for symptoms and metacognitive beliefs at pre-intervention, post-intervention and 12 weeks post-intervention
Eligibility Criteria
Inclusion Criteria: * two psychiatrists with the title of Deputy Chief Physician or above jointly determine that the above diagnostic criteria were met * education level of junior high school or above, without mental retardation or audio-visual disorders * participation in the study is voluntary, and the informed consent is signed by the patient or his/her guardian Exclusion Criteria: * loss of or insufficient self-awareness, the presence of hallucinations, delusions, and other psychotic symptoms * the presence of severe depression, or self-inflicted suicidal attempts and behaviors * the presence of a history of alcohol or drug abuse * refusal of psychotherapy, or the ineffectiveness of those who had been involved in a full course of psychotherapy.